shield

Welcome to JustMilk!

We are developing a low-cost Nipple Shield Delivery System (NSDS) to administer drugs or nutrients to breastfeeding infants in a safe, effective manner. The shield is currently in the initial testing and fundraising phases. It is our hope that the shield will soon be a major tool in the global fight against malnutrition, malaria, HIV/AIDS, and other health crises.

We're hiring!!

Interested in working with JustMilk in a voluntary or professional basis? We are looking to hire a post-doctoral level researcher in our pharmaceutical formulation and development team based in the UK with our partners at the University of Cambridge and University College London. We are also looking to hire a website manager and general logistics manager. If you are interested please enter your details here:

How the JustMilk device works:

A caregiver places the JustMilk shield over her breast before feeding her child. Inside the shield is a rapidly dispersible tablet or fabric insert containing one or more of (for example):

As milk passes through the insert, it picks up and delivers the medicine to the infant.

Potential Advantages:

Use of the NSDS would empower a breastfeeding mother by allowing her to personally administer medicines in a natural setting. Our system offers advantages over currently available methods for infant drug administration like liquid formulations or dispersible tablets. Liquid formulations have the following problems: high-cost, refrigeration requirements, accurate dosing difficulties, unpalatability, and the potential presence of harmful excipients. Dispersible tablets must be dissolved in potable water in a clean container, and also have issues with accurate dosing. No ideal drug delivery method exists, and the NSDS addresses each of these issues.

Nipple Shield

shield1

Insert

disk

Insert Packaging

packaging
Click to enlarge

JustMilk has received support from the US Agency for International Development (USAID), Gates Foundation and Clinton Global Initiative grants, public health charity FHI360, the University of Cambridge, and the National Collegiate Inventors and Innovators Alliance (NCIIA).